Key points New evidence has led to a change in the way that some patients with amyotrophic lateral sclerosis (ALS) are classified and treated. Based on the findings of a landmark trial,[1][1] the drug ...

SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, today announced an expansion of its ...

Management of newly diagnosed acute myeloid leukemia (AML) in patients deemed unfit for intensive chemotherapy is undergoing rapid transformation toward highly individualized regimens. The combination ...

The global next generation sequencing market is set to witness a growth rate of ~15% in the next 5 years. Rising demand for ...

Health-tech companies are designing models that identify patients at risk of developing cancer, and who might need more screening or preventive care.

In view of persistent fever and cough, and the new onset of an accentuated confluent maculopapular rash, the patient was ...

Huntington’s disease has been successfully treated for the first time using a gene therapy, which may be available in the US ...

This is clearly good news, though there is no claim of a cure and if it can be turned into a treatment, that will surely be ...

Preliminary results from a small trial offer the clearest evidence yet that the brain disease’s progression can be slowed.

You get older every day. But how old are your cells and organs, really?

An experimental gene therapy has slowed the progression of Huntington’s disease by 75 percent, according to results reported ...

An experimental gene therapy was found to slow the progression of Huntington’s disease in a “pivotal” study, according to drugmaker uniQure, marking a major step toward a potential first genetic ...